Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-05-28EVMN144GREGORY MOSS plan to sell securities of Evommune, Inc. under Form 144MEDIUM
GREGORY MOSS filed Form 144 to notify SEC of plan to sell 14223 units of Evommune, Inc. securities around 2026-05-28, with aggregate market value of $331,964.82. The total outstanding units is 36018372.0. The amount planned to be sold represents 0.04% of total outstanding units; ...
Small CapBiotechnology
2026-05-28CCCC144Mark Mossler plan to sell securities of C4 Therapeutics, Inc. under Form 144MEDIUM
Mark Mossler filed Form 144 to notify SEC of plan to sell 9087 units of C4 Therapeutics, Inc. securities around 2026-05-27, with aggregate market value of $35,484.74. The total outstanding units is 110567222.0. The amount planned to be sold represents 0.01% of total outstanding units; ...
Small CapBiotechnology
2026-05-28JAZZ144NEENA PATIL plan to sell securities of JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY under Form 144MEDIUM
NEENA PATIL filed Form 144 to notify SEC of plan to sell 1192 units of JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY securities around 2026-05-28, with aggregate market value of $282,468.24. The total outstanding units is 62742820.0. The amount planned to be sold represents 0.00% of total outstanding units; ...
Large CapBiotechnology
2026-05-28JAZZ144SAMANTHA PEARCE plan to sell securities of JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY under Form 144MEDIUM
SAMANTHA PEARCE filed Form 144 to notify SEC of plan to sell 6907 units of JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY securities around 2026-05-28, with aggregate market value of $1,625,976.87. The total outstanding units is 62742820.0. The amount planned to be sold represents 0.01% of total outstanding units; ...
Large CapBiotechnology